High school football and construction work have taken their toll on Justin Loebel's back. Though he is just 43, Loebel has already undergone fusion surgery to alleviate chronic back pain. It didn't ...

MIAMI, Feb. 12, 2026 /PRNewswire/ -- Vivex Biologics, Inc., a leading medical technology company developing and delivering innovative allografts for musculoskeletal and wound-care applications, today ...

CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery ...

Weeks after the Trump Media and Technology Group announced a merger with nuclear power company TAE Technologies, the new organization has unveiled plans for a fusion plant in the US — aiming to make ...

WASHINGTON, Dec 18 (Reuters) - Scientists and companies have been trying for decades to harness fusion energy, the process that fires the sun, to generate electricity on Earth. Fusion energy, the ...

President Donald Trump’s social media company, Trump Media & Technology Group (TMTG), said on Thursday that it’s merging with TAE Technologies, a Southern California-based company that has been ...

Spinal fusion has long been “the gold standard” in spine surgery, but motion-preserving techniques have become more attractive to physicians and patients in recent years. Spine surgeons discuss how ...

Nuclear fusion, which operates on the same principle that powers the sun, is expected to become a sustainable energy source for the future. To achieve fusion power generation, it is essential to ...

Trip Taylor: Good afternoon, everyone, and welcome to our third quarter 2025 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, ...

Image source: The Motley Fool. Treace Medical Concepts (NASDAQ:TMCI) reported decelerating growth driven by a shift in product sales mix and softness in its core lapoplasty business, citing reduced ...

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in Q3 2025 was still below original expectations and driven by lower-ASP ...